A9506 |
Tc-99m graphite crucible |
Cyclomedica Australia PTY Limited |
73814-0986-20 |
Technegas |
EACH |
1 |
50 |
50 |
50 |
A9513 |
Lutetium Lu 177 dotatat ther |
Advanced Accelerator Applications USA, Inc. |
69488-0003-01 |
Lutathera |
1 mCi |
20 |
1 |
200 |
200 |
A9521 |
Tc99m exametazime |
Jubilant Draximage Inc., dba Jubilant Radiopharma |
65174-0200-05 |
Technetium TC-99M Exametazime |
Per Study Dose, up to 25 millicuries |
1 |
1 |
1 |
1 |
A9543 |
Y90 ibritumomab, rx |
Acrotech Biopharma LLC |
72893-0007-04 |
Zevalin Y-91 |
UP TO 40 millicuries |
1 |
1 |
1 |
1 |
A9582 |
Iodine I-123 iobenguane |
GE Healthcare Inc. |
17156-0235-01 |
Adreview |
UP TO 15 millicuries |
5 |
1 |
1 |
1 |
A9584 |
Iodine I-123 ioflupane |
GE Healthcare Inc. |
17156-0210-01 |
Datscan |
Per Study Dose, up to 5 millicuries |
2.5 |
1 |
1 |
1 |
A9587 |
Gallium Ga-68 |
Advanced Accelerator Applications USA, Inc. |
69488-0001-40 |
Netspot |
0.1 mCi |
1 |
1 |
1 |
1 |
A9588 |
Fluciclovine F-18 |
Blue Earth Diagnostics Limited |
69932-0001-01 |
Axumin |
1 mCi |
1 |
1 |
1 |
1 |
A9591 |
Fluoroestradiol F 18 |
GE Healthcare Inc. |
72874-0001-01 |
Cerianna |
1 mCi |
50 |
1 |
6 |
6 |
A9592 |
Copper cu 64 dotatate diag |
Curium US LLC |
69945-0064-01 |
Detectnet |
1 mCi |
4 |
1 |
4 |
4 |
A9593 |
Gallium ga-68 psma-11 ucsf |
UCSF Radiopharmaceutical Facility |
24275-0525-01 |
Gallium Ga 68 PSMA |
1 mCi |
11 |
1 |
1 |
1 |
A9594 |
Gallium ga-68 psma-11, ucla |
UCLA Biomedical Cyclotron |
76394-2642-03 |
Gallium Ga 68 PSMA |
1 mCi |
12 |
1 |
1 |
1 |
A9595 |
Piflu f-18, dia 1 millicurie |
Progenics Pharmaceuticals, Inc. |
71258-0022-00 |
Pylarify |
1 millicurie |
1 |
1 |
9 |
9 |
A9595 |
Piflu f-18, dia 1 millicurie |
Progenics Pharmaceuticals, Inc. |
71258-0022-01 |
Pylarify |
1 mCi |
50 |
1 |
1 |
1 |
A9596 |
Gallium illuccix 1 millicure |
Telix Pharmaceuticals US Inc. |
74725-0100-25 |
Illuccix |
1 mCi |
1 |
1 |
1 |
1 |
A9596 |
Gallium illuccix 1 millicure |
Telix Pharmaceuticals US Inc. |
74725-0100-64 |
Illuccix |
1 mCi |
1 |
1 |
1 |
1 |
A9600 |
Sr89 strontium |
Q Biomed Inc |
72928-0089-01 |
Strontium Chloride Sr 89 |
PER MILLICURIE |
4 |
1 |
1 |
4 |
A9601 |
Flortaucipir inj 1 millicuri |
Eli Lilly and Company |
00002-1220-01 |
Tauvid |
1 mCi |
1 |
1 |
1 |
1 |
A9602 |
Fluorodopa f-18 diag per mci |
The Feinstein Institute for Medical Research |
13267-0346-57 |
Fluorodopa F18 |
1 mCi |
1 |
1 |
1 |
1 |
A9606 |
Radium Ra223 dichloride ther |
Bayer HealthCare Pharmaceuticals Inc. |
50419-0208-01 |
Xofigo |
1 mCi |
6 |
1 |
1 |
1 |
A9607 |
Lutetium lu 177 vipivotide |
Advanced Accelerator Applications USA, Inc. |
69488-0010-61 |
Pluvicto |
1 mCi |
1 |
1 |
1 |
1 |
A9608 |
Flotufolastat f18 diag 1 mci |
Blue Earth Diagnostics Limited |
69932-0002-01 |
Posluma |
1 mCi |
1 |
1 |
1 |
8 |
A9608 |
Flotufolastat f18 diag 1 mci |
Blue Earth Diagnostics Limited |
69932-0002-50 |
Posluma |
1 millicurie |
25 |
1 |
1 |
1 |
A9611 |
Flurpiridaz f18, diag, 1 mci |
GE Healthcare Inc. |
00407-8787-01 |
Flyrcado |
1 mCi |
1 |
1 |
1 |
1 |
A9615 |
Inj, pegulicianine, 1 mg |
Lumicell Inc. |
82292-0040-10 |
Lumisight |
1 MG |
1 |
10 |
39 |
390 |
A9616 |
Gallium gozellix 1 millicuri |
Telix Innovations SA |
84552-0500-25 |
Gozellix |
1 MCI |
1 |
1 |
1 |
1 |
A9616 |
Gallium gozellix 1 millicuri |
Telix Innovations SA |
84552-0500-64 |
Gozellix |
1 MCI |
1 |
1 |
1 |
1 |
A9697 |
Inj, magtrace per study dose |
Endomagnetics Inc. |
60391-021024 |
Magtrace |
PER STUDY DOSE |
2 |
10 |
1 |
10 |
A9800 |
Gallium locametz 1 millicuri |
Advanced Accelerator Applications USA, Inc. |
69488-0017-61 |
Locametz |
1 mCi |
1 |
1 |
1 |
1 |
C9089 |
Bupivacaine implant, 1 mg |
Innocoll Pharmaceuticals |
51715-0100-04 |
Xaracoll |
1 MG |
1 |
12 |
100 |
1200 |
C9089 |
Bupivacaine implant, 1 mg |
Innocoll Pharmaceuticals |
51715-0100-10 |
Xaracoll |
1 MG |
1 |
30 |
100 |
3000 |
C9144 |
Inj, bupivacaine (posimir) |
Innocoll Pharmaceuticals |
51715-0660-10 |
Posimir |
1 MG |
5 |
10 |
660 |
6600 |
C9145 |
Inj, aponvie, 1 mg |
Heron Therapeutics |
47426-0401-10 |
Aponvie |
1 MG |
4.4 |
10 |
32 |
320 |
C9250 |
Artiss fibrin sealant |
Baxter Healthcare Corporation |
00338-9637-01 |
Artiss |
2 ML |
2 |
1 |
1 |
1 |
C9250 |
Artiss fibrin sealant |
Baxter Healthcare Corporation |
00338-9639-01 |
Artiss |
2 ML |
4 |
1 |
2 |
2 |
C9250 |
Artiss fibrin sealant |
Baxter Healthcare Corporation |
00338-9641-01 |
Artiss |
2 ML |
10 |
1 |
5 |
5 |
C9257 |
Bevacizumab injection |
Genentech, Inc. |
50242-0060-01 |
Avastin |
0.25 MG |
4 |
1 |
400 |
400 |
C9257 |
Bevacizumab injection |
Genentech, Inc. |
50242-0061-01 |
Avastin |
0.25 MG |
16 |
1 |
1600 |
1600 |
C9305 |
Inj, nipocalimab-aahu, 3 mg |
Janssen Biotech, Inc. |
57894-0800-01 |
Imaavy |
3 MG |
1.62 |
1 |
100 |
100 |
C9305 |
Inj, nipocalimab-aahu, 3 mg |
Janssen Biotech, Inc. |
57894-0801-01 |
Imaavy |
3 MG |
6.5 |
1 |
400 |
400 |
C9306 |
Telisotuzumab vedotin-tllv |
AbbVie Inc. |
00074-1044-01 |
Emrelis |
1 MG |
1 |
1 |
20 |
20 |
C9306 |
Telisotuzumab vedotin-tllv |
AbbVie Inc. |
00074-1055-01 |
Emrelis |
1 MG |
1 |
1 |
100 |
100 |
C9460 |
Injection, cangrelor |
Chiesi USA, Inc. |
10122-0620-10 |
Kengreal |
1 MG |
1 |
10 |
50 |
500 |
C9482 |
Sotalol hydrochloride IV |
Altathera Pharmaceuticals, LLC |
69724-0112-10 |
Sotalol |
1 MG |
10 |
1 |
150 |
150 |
J0139 |
Inj, adalimumab, 1 mg |
AbbVie Inc. |
00074-3799-02 |
Humira |
1 MG |
0.8 |
2 |
40 |
80 |
J0139 |
Inj, adalimumab, 1 mg |
AbbVie Inc. |
00074-4339-02 |
Humira |
1 MG |
0.8 |
2 |
40 |
80 |
J0139 |
Inj, adalimumab, 1 mg |
AbbVie Inc. |
00074-4339-06 |
Humira |
1 MG |
0.8 |
6 |
40 |
240 |
J0139 |
Inj, adalimumab, 1 mg |
AbbVie Inc. |
00074-4339-07 |
Humira |
1 MG |
0.8 |
4 |
40 |
160 |
J0184 |
Inj, amisulpride, 1 mg |
Acacia Pharma Ltd |
71390-0125-20 |
Barhemsys |
1 MG |
2 |
10 |
5 |
50 |
J0184 |
Inj, amisulpride, 1 mg |
Acacia Pharma Ltd |
71390-0125-50 |
Barhemsys |
1 MG |
4 |
10 |
10 |
100 |
J0208 |
Inj, pedmark, 100 mg |
Fennec Pharmaceuticals, Inc. |
73077-0010-01 |
Sodium Thiosulfate |
100 MG |
100 |
1 |
125 |
125 |
J0211 |
Inj, nithiodote, 3mg / 125mg |
Hope Pharmaceuticals |
60267-0812-00 |
Nithiodote |
3 MG AND 125 MG |
60 |
1 |
100 |
100 |
J0391 |
Inj, artesunate, 1mg |
Amivas, Inc |
73607-0011-11 |
Artesunate |
1 MG |
1 |
2 |
110 |
220 |
J0458 |
Aztreonam/avibactam 10 mg |
AbbVie Inc |
00074-3878-10 |
Emblaveo |
10 MG |
1 |
10 |
200 |
2000 |
J0567 |
Inj., cerliponase alfa 1 mg |
BioMarin Pharmaceutical Inc. |
68135-0811-02 |
Brineura |
1 MG |
1 |
2 |
150 |
300 |
J0599 |
Inj., haegarda 10 units |
CSL Behring L.L.C. |
63833-0828-02 |
Haegarda |
10 UNITS |
1 |
1 |
200 |
200 |
J0599 |
Inj., haegarda 10 units |
CSL Behring L.L.C. |
63833-0829-02 |
Haegarda |
10 UNITS |
1 |
1 |
300 |
300 |
J0630 |
Calcitonin salmon injection |
Hikma Pharmaceuticals USA Inc. |
24201-0400-02 |
Calcitonin Salmon |
400 UNITS |
2 |
1 |
1 |
1 |
J0630 |
Calcitonin salmon injection |
Endo USA, Inc. |
42023-0205-01 |
Calcitonin Salmon |
400 UNITS |
2 |
1 |
1 |
1 |
J0630 |
Calcitonin salmon injection |
Dr Reddy's Laboratories, Inc. |
43598-0051-11 |
Calcitonin Salmon |
400 UNITS |
2 |
1 |
1 |
1 |
J0630 |
Calcitonin salmon injection |
FreseniUS Kabi USA, LLC |
63323-0865-02 |
Calcitonin-Salmon |
400 UNITS |
2 |
1 |
1 |
1 |
J0630 |
Calcitonin salmon injection |
Cipla USA, Inc. |
69097-0770-32 |
Calcitonin-Salmon |
400 UNITS |
2 |
1 |
1 |
1 |
J0630 |
Calcitonin salmon injection |
Mylan Institutional LLC |
67457-0675-02 |
Miacalcin |
400 UNITS |
2 |
1 |
1 |
1 |
J0630 |
Calcitonin salmon injection |
Mylan Institutional LLC |
72078-0038-02 |
Miacalcin |
400 UNITS |
2 |
1 |
1 |
1 |
J0630 |
Calcitonin salmon injection |
Mylan Institutional LLC |
72078-0039-02 |
Miacalcin |
400 UNITS |
2 |
1 |
1 |
1 |
J0668 |
Instill, bupivac and meloxic |
Heron Therapeutics |
47426-0301-02 |
Zynrelef |
1 MG - 0.03 MG |
14 |
1 |
400 |
400 |
J0668 |
Instill, bupivac and meloxic |
Heron Therapeutics |
47426-0303-01 |
Zynrelef |
1 MG - 0.03 MG |
7 |
1 |
200 |
200 |
J0668 |
Instill, bupivac and meloxic |
Heron Therapeutics |
47426-0501-02 |
Zynrelef |
1 MG - 0.03 MG |
14 |
1 |
400 |
400 |
J0675 |
Inj, carboprost, 0.1 mg |
Pfizer Inc |
00009-0856-08 |
Hemabate |
0.1 MG |
1 |
10 |
2.5 |
25 |
J0681 |
Inj ceftobipole medocarl 3mg |
La Jolla Pharmaceutical Company |
68547-0578-10 |
Zevtera |
3 MG |
1 |
10 |
166.666666666667 |
1667 |
J0716 |
Centruroides immune f(ab) |
Rare Disease Therapeutics, Inc. |
66621-0150-02 |
Anascorp |
UP TO 120 MG |
1 |
1 |
1 |
1 |
J0759 |
Inj, clevidipine, 1 mg |
Chiesi USA, Inc. |
10122-0610-10 |
Cleviprex |
1 MG |
50 |
10 |
25 |
250 |
J0759 |
Inj, clevidipine, 1 mg |
Chiesi USA, Inc. |
10122-0611-10 |
Cleviprex |
1 MG |
100 |
10 |
50 |
500 |
J0879 |
Difelikefalin, esrd on dialy |
Vifor (International) Inc. |
59353-0065-01 |
Korsuva |
0.1 MCG |
1.3 |
1 |
65 |
650 |
J0879 |
Difelikefalin, esrd on dialy |
Vifor (International) Inc. |
59353-0065-12 |
Korsuva |
0.1 MCG |
1.3 |
1 |
65 |
7800 |
J0891 |
Argatroban nonesrd (accord) |
Accord Healthcare Inc |
16729-0430-43 |
Argatroban |
1 MG |
50 |
10 |
50 |
500 |
J0911 |
Inst tauro 1.35mg/hep 100u |
CorMedix Inc. |
72990-0103-10 |
Defencath |
taurolidine 1.35 mg and heparin sodium 100 units |
3 |
10 |
30 |
300 |
J0911 |
Inst tauro 1.35mg/hep 100u |
CorMedix Inc. |
72990-0105-10 |
Defencath |
taurolidine 1.35 mg and heparin sodium 100 units |
5 |
10 |
50 |
500 |
J1097 |
Phenylep ketorolac opth soln |
Omeros Corporation |
62225-0600-04 |
Omidria |
1 ML |
4 |
4 |
4 |
16 |
J1097 |
Phenylep ketorolac opth soln |
Rayner Surgical Inc. |
82604-0600-04 |
Omidria |
1 ML |
4 |
4 |
4 |
16 |
J1105 |
Dexmedetomidine film, 1 mcg |
BioXcel Therapeutics, Inc. |
81092-1120-01 |
Igalmi |
1 MCG |
10 |
1 |
1200 |
1200 |
J1105 |
Dexmedetomidine film, 1 mcg |
BioXcel Therapeutics, Inc. |
81092-1180-01 |
Igalmi |
1 MCG |
10 |
1 |
1800 |
1800 |
J1307 |
Inj, crovalimab-akkz, 10 mg |
Genentech, Inc. |
50242-0115-01 |
Piasky |
10 MG |
2 |
1 |
34 |
34 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0100-10 |
Hemgenix |
Per Therapeutic Dose |
10 |
10 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0110-11 |
Hemgenix |
Per Therapeutic Dose |
10 |
11 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0120-12 |
Hemgenix |
Per Therapeutic Dose |
10 |
12 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0130-13 |
Hemgenix |
Per Therapeutic Dose |
10 |
13 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0140-14 |
Hemgenix |
Per Therapeutic Dose |
10 |
14 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0150-15 |
Hemgenix |
Per Therapeutic Dose |
10 |
15 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0160-16 |
Hemgenix |
Per Therapeutic Dose |
10 |
16 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0170-17 |
Hemgenix |
Per Therapeutic Dose |
10 |
17 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0180-18 |
Hemgenix |
Per Therapeutic Dose |
10 |
18 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0190-19 |
Hemgenix |
Per Therapeutic Dose |
10 |
19 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0200-20 |
Hemgenix |
Per Therapeutic Dose |
10 |
20 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0210-21 |
Hemgenix |
Per Therapeutic Dose |
10 |
21 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0220-22 |
Hemgenix |
Per Therapeutic Dose |
10 |
22 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0230-23 |
Hemgenix |
Per Therapeutic Dose |
10 |
23 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0240-24 |
Hemgenix |
Per Therapeutic Dose |
10 |
24 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0250-25 |
Hemgenix |
Per Therapeutic Dose |
10 |
25 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0260-26 |
Hemgenix |
Per Therapeutic Dose |
10 |
26 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0270-27 |
Hemgenix |
Per Therapeutic Dose |
10 |
27 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0280-28 |
Hemgenix |
Per Therapeutic Dose |
10 |
28 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0290-29 |
Hemgenix |
Per Therapeutic Dose |
10 |
29 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0300-30 |
Hemgenix |
Per Therapeutic Dose |
10 |
30 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0310-31 |
Hemgenix |
Per Therapeutic Dose |
10 |
31 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0320-32 |
Hemgenix |
Per Therapeutic Dose |
10 |
32 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0330-33 |
Hemgenix |
Per Therapeutic Dose |
10 |
33 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0340-34 |
Hemgenix |
Per Therapeutic Dose |
10 |
34 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0350-35 |
Hemgenix |
Per Therapeutic Dose |
10 |
35 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0360-36 |
Hemgenix |
Per Therapeutic Dose |
10 |
36 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0370-37 |
Hemgenix |
Per Therapeutic Dose |
10 |
37 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0380-38 |
Hemgenix |
Per Therapeutic Dose |
10 |
38 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0390-39 |
Hemgenix |
Per Therapeutic Dose |
10 |
39 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0400-40 |
Hemgenix |
Per Therapeutic Dose |
10 |
40 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0410-41 |
Hemgenix |
Per Therapeutic Dose |
10 |
41 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0420-42 |
Hemgenix |
Per Therapeutic Dose |
10 |
42 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0430-43 |
Hemgenix |
Per Therapeutic Dose |
10 |
43 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0440-44 |
Hemgenix |
Per Therapeutic Dose |
10 |
44 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0450-45 |
Hemgenix |
Per Therapeutic Dose |
10 |
45 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0460-46 |
Hemgenix |
Per Therapeutic Dose |
10 |
46 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0470-47 |
Hemgenix |
Per Therapeutic Dose |
10 |
47 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring L.L.C. |
00053-0480-48 |
Hemgenix |
Per Therapeutic Dose |
10 |
48 |
1 |
1 |
J1412 |
Inj roctavian ml 2x10^13vc g |
BioMarin Pharmaceutical Inc. |
68135-0927-48 |
Roctavian |
1 ML |
8 |
1 |
8 |
8 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0501-10 |
Elevidys |
Per Therapeutic Dose |
1 |
10 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0502-11 |
Elevidys |
Per Therapeutic Dose |
1 |
11 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0503-12 |
Elevidys |
Per Therapeutic Dose |
1 |
12 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0504-13 |
Elevidys |
Per Therapeutic Dose |
1 |
13 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0505-14 |
Elevidys |
Per Therapeutic Dose |
1 |
14 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0506-15 |
Elevidys |
Per Therapeutic Dose |
1 |
15 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0507-16 |
Elevidys |
Per Therapeutic Dose |
1 |
16 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0508-17 |
Elevidys |
Per Therapeutic Dose |
1 |
17 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0509-18 |
Elevidys |
Per Therapeutic Dose |
1 |
18 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0510-19 |
Elevidys |
Per Therapeutic Dose |
1 |
19 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0511-20 |
Elevidys |
Per Therapeutic Dose |
1 |
20 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0512-21 |
Elevidys |
Per Therapeutic Dose |
1 |
21 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0513-22 |
Elevidys |
Per Therapeutic Dose |
1 |
22 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0514-23 |
Elevidys |
Per Therapeutic Dose |
1 |
23 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0515-24 |
Elevidys |
Per Therapeutic Dose |
1 |
24 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0516-25 |
Elevidys |
Per Therapeutic Dose |
1 |
25 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0517-26 |
Elevidys |
Per Therapeutic Dose |
1 |
26 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0518-27 |
Elevidys |
Per Therapeutic Dose |
1 |
27 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0519-28 |
Elevidys |
Per Therapeutic Dose |
1 |
28 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0520-29 |
Elevidys |
Per Therapeutic Dose |
1 |
29 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0521-30 |
Elevidys |
Per Therapeutic Dose |
1 |
30 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0522-31 |
Elevidys |
Per Therapeutic Dose |
1 |
31 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0523-32 |
Elevidys |
Per Therapeutic Dose |
1 |
32 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0524-33 |
Elevidys |
Per Therapeutic Dose |
1 |
33 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0525-34 |
Elevidys |
Per Therapeutic Dose |
1 |
34 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0526-35 |
Elevidys |
Per Therapeutic Dose |
1 |
35 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0527-36 |
Elevidys |
Per Therapeutic Dose |
1 |
36 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0528-37 |
Elevidys |
Per Therapeutic Dose |
1 |
37 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0529-38 |
Elevidys |
Per Therapeutic Dose |
1 |
38 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0530-39 |
Elevidys |
Per Therapeutic Dose |
1 |
39 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0531-40 |
Elevidys |
Per Therapeutic Dose |
1 |
40 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0532-41 |
Elevidys |
Per Therapeutic Dose |
1 |
41 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0533-42 |
Elevidys |
Per Therapeutic Dose |
1 |
42 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0534-43 |
Elevidys |
Per Therapeutic Dose |
1 |
43 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0535-44 |
Elevidys |
Per Therapeutic Dose |
1 |
44 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0536-45 |
Elevidys |
Per Therapeutic Dose |
1 |
45 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0537-46 |
Elevidys |
Per Therapeutic Dose |
1 |
46 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0538-47 |
Elevidys |
Per Therapeutic Dose |
1 |
47 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0539-48 |
Elevidys |
Per Therapeutic Dose |
1 |
48 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0540-49 |
Elevidys |
Per Therapeutic Dose |
1 |
49 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0541-50 |
Elevidys |
Per Therapeutic Dose |
1 |
50 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0542-51 |
Elevidys |
Per Therapeutic Dose |
1 |
51 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0543-52 |
Elevidys |
Per Therapeutic Dose |
1 |
52 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0544-53 |
Elevidys |
Per Therapeutic Dose |
1 |
53 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0545-54 |
Elevidys |
Per Therapeutic Dose |
1 |
54 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0546-55 |
Elevidys |
Per Therapeutic Dose |
1 |
55 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0547-56 |
Elevidys |
Per Therapeutic Dose |
1 |
56 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0548-57 |
Elevidys |
Per Therapeutic Dose |
1 |
57 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0549-58 |
Elevidys |
Per Therapeutic Dose |
1 |
58 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0550-59 |
Elevidys |
Per Therapeutic Dose |
1 |
59 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0551-60 |
Elevidys |
Per Therapeutic Dose |
1 |
60 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0552-61 |
Elevidys |
Per Therapeutic Dose |
1 |
61 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0553-62 |
Elevidys |
Per Therapeutic Dose |
1 |
62 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0554-63 |
Elevidys |
Per Therapeutic Dose |
1 |
63 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0555-64 |
Elevidys |
Per Therapeutic Dose |
1 |
64 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0556-65 |
Elevidys |
Per Therapeutic Dose |
1 |
65 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0557-66 |
Elevidys |
Per Therapeutic Dose |
1 |
66 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0558-67 |
Elevidys |
Per Therapeutic Dose |
1 |
67 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0559-68 |
Elevidys |
Per Therapeutic Dose |
1 |
68 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0560-69 |
Elevidys |
Per Therapeutic Dose |
1 |
69 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics, Inc. |
60923-0561-70 |
Elevidys |
Per Therapeutic Dose |
1 |
70 |
1 |
1 |
J1414 |
Inj, beqvez, per tx dose |
Pfizer Inc |
00069-2004-04 |
Beqvez |
Per Therapeutic Dose |
1 |
4 |
1 |
1 |
J1414 |
Inj, beqvez, per tx dose |
Pfizer Inc |
00069-2005-05 |
Beqvez |
Per Therapeutic Dose |
1 |
5 |
1 |
1 |
J1414 |
Inj, beqvez, per tx dose |
Pfizer Inc |
00069-2006-06 |
Beqvez |
Per Therapeutic Dose |
1 |
6 |
1 |
1 |
J1414 |
Inj, beqvez, per tx dose |
Pfizer Inc |
00069-2007-07 |
Beqvez |
Per Therapeutic Dose |
1 |
7 |
1 |
1 |
J1426 |
Injection, casimersen, 10 mg |
Sarepta Therapeutics, Inc. |
60923-0227-02 |
Amondys 45 |
10 MG |
2 |
1 |
10 |
10 |
J1428 |
Injection, eteplirsen |
Sarepta Therapeutics, Inc. |
60923-0284-10 |
Exondys 51 |
10 MG |
10 |
1 |
50 |
50 |
J1428 |
Injection, eteplirsen |
Sarepta Therapeutics, Inc. |
60923-0363-02 |
Exondys 51 |
10 MG |
2 |
1 |
10 |
10 |
J1438 |
Etanercept injection |
Amgen Inc. |
58406-0425-34 |
Enbrel |
25 MG |
1 |
4 |
1 |
4 |
J1451 |
Fomepizole, 15 mg |
American Regent, Inc. |
00517-0710-01 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1451 |
Fomepizole, 15 mg |
Sagent Pharmaceuticals |
25021-0829-02 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1451 |
Fomepizole, 15 mg |
Mylan Institutional LLC |
67457-0211-02 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1451 |
Fomepizole, 15 mg |
Zydus Pharmaceuticals (USA) Inc. |
70710-1478-01 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1595 |
Injection glatiramer acetate |
Teva Neuroscience, Inc. |
68546-0317-30 |
Copaxone |
20 MG |
1 |
30 |
1 |
30 |
J1595 |
Injection glatiramer acetate |
Teva Neuroscience, Inc. |
68546-0325-12 |
Copaxone |
20 MG |
1 |
12 |
2 |
24 |
J1612 |
Inj glucagon (gvoke) 0.01 mg |
Xeris Pharmaceuticals, Inc. |
72065-0140-11 |
Gvoke Kit |
0.01 MG |
1 |
1 |
100 |
100 |
J1742 |
Ibutilide fumarate injection |
Heritage Pharmaceuticals Inc. |
23155-0326-31 |
Ibutilide Fumarate |
1 MG |
10 |
1 |
1 |
1 |
J1742 |
Ibutilide fumarate injection |
Mylan Institutional LLC |
67457-0366-10 |
Ibutilide Fumarate |
1 MG |
10 |
1 |
1 |
1 |
J1742 |
Ibutilide fumarate injection |
Pfizer Inc |
00009-3794-01 |
Corvert |
1 MG |
10 |
1 |
1 |
1 |
J1742 |
Ibutilide fumarate injection |
Pfizer Inc |
00009-3794-22 |
Corvert |
1 MG |
10 |
1 |
1 |
1 |
J1744 |
Icatibant injection |
Hikma Pharmaceuticals USA Inc. |
24201-0207-01 |
Icatibant |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
Takeda Pharmaceuticals America, Inc. |
54092-0702-02 |
Icatibant |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
Takeda Pharmaceuticals America, Inc. |
54092-0702-03 |
Icatibant |
1 MG |
3 |
3 |
30 |
90 |
J1744 |
Icatibant injection |
Apotex Corp |
60505-6214-01 |
Icatibant |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
FreseniUS Kabi USA, LLC |
63323-0574-86 |
Icatibant |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
FreseniUS Kabi USA, LLC |
63323-0574-93 |
Icatibant |
1 MG |
3 |
3 |
30 |
90 |
J1744 |
Icatibant injection |
Cipla USA, Inc. |
69097-0664-34 |
Icatibant |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
Cipla USA, Inc. |
69097-0664-68 |
Icatibant |
1 MG |
3 |
3 |
30 |
90 |
J1807 |
Inj, ethacrynate sod, 1 mg |
Endo USA, Inc. |
42023-0157-01 |
Ethacrynate Sodium |
1 MG |
1 |
1 |
50 |
50 |
J1833 |
Inj, isavuconazonium sulfate |
Astellas Pharma US, Inc. |
00469-0420-01 |
Cresemba |
1 MG |
1 |
1 |
372 |
372 |
J1834 |
Inj, isoniazid, 1 mg |
Sandoz Inc. |
00781-3056-70 |
Isoniazid Injection |
1 MG |
10 |
1 |
1000 |
1000 |
J2186 |
Inj., meropenem, vaborbactam |
Melinta Therapeutics, LLC |
70842-0120-06 |
Vabomere |
(10 MG/10MG) 20 MG |
1 |
6 |
100 |
600 |
J2265 |
Minocycline hydrochloride |
Melinta Therapeutics, LLC |
70842-0160-10 |
Minocin |
1 MG |
1 |
10 |
100 |
1000 |
J2326 |
Injection, nusinersen |
Biogen Inc. |
64406-0058-01 |
Spinraza |
0.1 MG |
5 |
1 |
120 |
120 |
J2547 |
Injection, peramivir |
BioCryst Pharmaceuticals, Inc. |
72769-0181-03 |
Rapivab |
1 MG |
20 |
3 |
200 |
600 |
J2561 |
Inj, sezaby, 1 mg |
Sun Pharmaceutical Industries, Inc. |
62756-0301-01 |
Sezaby |
1 MG |
1 |
1 |
100 |
100 |
J2801 |
Inj, rykindo, 0.5 mg |
Shandong Luye Pharmaceutical |
72526-0101-11 |
Rykindo |
0.5 MG |
1 |
1 |
25 |
25 |
J2801 |
Inj, rykindo, 0.5 mg |
Shandong Luye Pharmaceutical |
72526-0102-11 |
Rykindo |
0.5 MG |
1 |
1 |
50 |
50 |
J2801 |
Inj, rykindo, 0.5 mg |
Shandong Luye Pharmaceutical |
72526-0103-11 |
Rykindo |
0.5 MG |
1 |
1 |
75 |
75 |
J2801 |
Inj, rykindo, 0.5 mg |
Shandong Luye Pharmaceutical |
72526-0104-11 |
Rykindo |
0.5 MG |
1 |
1 |
100 |
100 |
J2840 |
Injection, sebelipase alfa |
Alexion Pharmaceuticals, Inc. |
25682-0007-01 |
Kanuma |
1 MG |
10 |
1 |
20 |
20 |
J2850 |
Inj secretin synthetic human |
ChiRhoClin, Inc |
67066-0005-01 |
Chirhostim |
1 MCG |
1 |
1 |
16 |
16 |
J2993 |
Reteplase injection |
Chiesi USA, Inc. |
10122-0141-02 |
Retavase |
18.1 MG |
1 |
2 |
1 |
2 |
J2998 |
Inj plasminogen tvmh 1mg |
Kedrion Biopharma Inc |
70573-0099-02 |
Ryplazim |
1 MG |
1 |
1 |
68.8 |
69 |
J3357 |
Ustekinumab injection |
Janssen Biotech, Inc. |
57894-0060-02 |
Stelara |
1 MG |
0.5 |
1 |
45 |
45 |
J3357 |
Ustekinumab injection |
Janssen Biotech, Inc. |
57894-0060-03 |
Stelara |
1 MG |
0.5 |
1 |
45 |
45 |
J3357 |
Ustekinumab injection |
Janssen Biotech, Inc. |
57894-0061-03 |
Stelara |
1 MG |
1 |
1 |
90 |
90 |
J3357 |
Ustekinumab injection |
JANSSEN BIOTECH, INC. |
57894-0440-01 |
Ustekinumab |
1 MG |
0.5 |
1 |
45 |
45 |
J3357 |
Ustekinumab injection |
JANSSEN BIOTECH, INC. |
57894-0440-03 |
Ustekinumab |
1 MG |
0.5 |
1 |
45 |
45 |
J3357 |
Ustekinumab injection |
JANSSEN BIOTECH, INC. |
57894-0441-01 |
Ustekinumab |
1 MG |
1 |
1 |
90 |
90 |
J3391 |
Inj, atidarsagene autotemcel |
Orchard Therapeutics Ltd |
83222-0200-01 |
Lenmeldy |
Per Treatment Dose |
1 |
1 |
1 |
1 |
J3392 |
Inj, exagamglogene autotem |
Vertex Pharmaceuticals, Inc. |
51167-0290-09 |
Casgevy |
Per Treatment |
1 |
1 |
1 |
1 |
J3392 |
Inj, exagamglogene autotem |
Roslin Cell Therapies Limited |
83932-0290-09 |
Casgevy |
Per Treatment |
1 |
1 |
1 |
1 |
J3393 |
Inj, betibeglogene autotemce |
Bluebird Bio, Inc. |
73554-3111-01 |
Zynteglo |
Per Therapeutic Dose |
20 |
1 |
1 |
1 |
J3394 |
Inj, lovotibeglogene autotem |
Bluebird Bio, Inc. |
73554-1111-01 |
Lyfgenia |
Per Treatment |
20 |
1 |
1 |
1 |
J3397 |
Inj., vestronidase alfa-vjbk |
Ultragenyx Pharmaceutical Inc. |
69794-0001-01 |
Mepsevii |
1 MG |
5 |
1 |
10 |
10 |
J3398 |
Inj luxturna 1 billion vec g |
Spark Therapeutics, Inc. |
71394-0415-01 |
Luxturna |
1 billion vector genomes |
0.5 |
1 |
150 |
150 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0120-02 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
16.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0121-03 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
19.3 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0122-03 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
22.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0123-03 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
24.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0124-04 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
27.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0125-04 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
30.4 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0126-04 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
33.2 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0127-05 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
35.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0128-05 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
38.7 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0129-05 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
41.5 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0130-06 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
44.2 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0131-06 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
47 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0132-06 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
49.8 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0133-07 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
52.5 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0134-07 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
55.3 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0135-07 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
58.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0136-08 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
60.8 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0137-08 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
63.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0138-08 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
66.4 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0139-09 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
69.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0140-09 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
71.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
Novartis Gene Therapies, Inc. |
71894-0141-09 |
Zolgensma |
Per tx dose (up to 5 x10^15 vg?) |
74.7 |
1 |
1 |
1 |
J3403 |
Revakinagene, per implant |
Neurotech Pharmaceuticals Inc |
82958-0501-01 |
Encelto |
PER IMPLANT |
1 |
1 |
1 |
1 |
J3424 |
Inj hydroxocobalamin iv 25mg |
Meridian Medical Technologies LLC |
11704-0370-01 |
Cyanokit |
25 MG |
1 |
1 |
200 |
200 |
J3424 |
Inj hydroxocobalamin iv 25mg |
BTG International Inc. |
50633-0310-11 |
Cyanokit |
25 MG |
1 |
1 |
200 |
200 |
J7165 |
Inj, human-lans, per i.u |
Octapharma USA Inc. |
68982-0261-01 |
Balfaxar |
PER FACTOR IX IU |
1 |
1 |
1 |
1 |
J7165 |
Inj, human-lans, per i.u |
Octapharma USA Inc. |
68982-0261-02 |
Balfaxar |
PER FACTOR IX IU |
1 |
1 |
1 |
1 |
J7168 |
Prothrombin complex kcentra |
CSL Behring L.L.C. |
63833-0386-02 |
Kcentra |
1 IU |
1 |
1 |
1 |
1 |
J7168 |
Prothrombin complex kcentra |
CSL Behring L.L.C. |
63833-0387-02 |
Kcentra |
1 IU |
1 |
1 |
1 |
1 |
J7169 |
Inj andexxa, 10 mg |
AstraZeneca Pharmaceuticals LP |
00310-3200-04 |
Andexxa |
10 MG |
1 |
4 |
20 |
80 |
J7169 |
Inj andexxa, 10 mg |
AstraZeneca Pharmaceuticals LP |
00310-3200-05 |
Andexxa |
10 MG |
1 |
5 |
20 |
100 |
J7169 |
Inj andexxa, 10 mg |
AstraZeneca Pharmaceuticals LP |
69853-0102-01 |
Andexxa |
10 MG |
1 |
4 |
20 |
80 |
J7174 |
Injection fitusiran 0.04 mg |
Genzyme Corporation |
58468-0347-01 |
Qfitlia |
0.04 MG |
0.2 |
1 |
500 |
500 |
J7174 |
Injection fitusiran 0.04 mg |
Genzyme Corporation |
58468-0348-01 |
Qfitlia |
0.04 MG |
0.5 |
1 |
1250 |
1250 |
J7352 |
Afamelanotide implant, 1 mg |
Clinuvel Inc. |
73372-0116-01 |
Scenesse |
1 MG |
1 |
1 |
16 |
16 |
J7353 |
Anacaulase-bcdb 8.8% gel 1 g |
Vericel Corporation |
69866-2002-03 |
NexoBrid |
1 GM (OF 8.8% GEL) |
1 |
1 |
22 |
22 |
J7353 |
Anacaulase-bcdb 8.8% gel 1 g |
Vericel Corporation |
69866-2005-03 |
NexoBrid |
1 GM (OF 8.8% GEL) |
1 |
1 |
55 |
55 |
J7501 |
Azathioprine parenteral |
Hikma Pharmaceuticals USA Inc. |
00143-9566-01 |
Azathioprine |
100 MG |
1 |
1 |
1 |
1 |
J9174 |
Inj, docetaxel (beizray) 1mg |
Zhuhai Beihai Biotech Ltd |
83513-0010-01 |
Beizray |
1 MG |
4 |
2 |
80 |
160 |
J9220 |
Indigotindisulfonate sod 1mg |
Apollo Pharmaceuticals |
81284-0315-05 |
Bludigo |
1 MG |
5 |
5 |
40 |
200 |
J9302 |
Ofatumumab injection |
Novartis Pharmaceuticals Corporation |
00078-0669-13 |
Arzerra |
10 MG |
5 |
3 |
10 |
30 |
J9302 |
Ofatumumab injection |
Novartis Pharmaceuticals Corporation |
00078-0690-61 |
Arzerra |
10 MG |
50 |
1 |
100 |
100 |
J9313 |
Inj., lumoxiti, 0.01 mg |
AstraZeneca Pharmaceuticals LP |
00310-4700-01 |
Lumoxiti |
0.01 MG |
1 |
1 |
100 |
100 |
J9313 |
Inj., lumoxiti, 0.01 mg |
AstraZeneca Pharmaceuticals LP |
73380-4700-01 |
Lumoxiti |
0.01 MG |
1 |
1 |
100 |
100 |
J9376 |
Inj pozelimab-bbfg, 1 mg |
Regeneron Pharmaceuticals, Inc. |
61755-0014-01 |
Veopoz |
1 MG |
2 |
1 |
400 |
400 |
J9600 |
Porfimer sodium injection |
Pinnacle Biologics, Inc. |
76128-0155-75 |
Photofrin |
75 MG |
1 |
1 |
1 |
1 |
Q2058 |
Obecbtge autol up to 400 mil |
Autolus Inc. |
83047-0410-04 |
Aucatzyl |
Per Therapeutic Dose |
1 |
1 |
1 |
2 |
Q3027 |
Inj beta interferon im 1 mcg |
Biogen Inc. |
59627-0222-05 |
Avonex |
1 MCG |
1 |
4 |
30 |
120 |
Q3027 |
Inj beta interferon im 1 mcg |
Biogen Inc. |
59627-0333-04 |
Avonex Pen |
1 MCG |
1 |
4 |
30 |
120 |
Q5136 |
Inj. denosumab-bbdz, 1 mg |
Sandoz Inc. |
61314-0228-94 |
Wyost |
1 MG |
1.7 |
1 |
120 |
120 |
Q5136 |
Inj. denosumab-bbdz, 1 mg |
Sandoz Inc. |
61314-0240-63 |
Jubbonti |
1 MG |
1 |
1 |
60 |
60 |
Q5140 |
Inj adalimumab-fkjp, 1 mg |
Mylan Specialty L.P. |
49502-0380-02 |
Hulio |
1 MG |
0.8 |
1 |
40 |
80 |
Q5140 |
Inj adalimumab-fkjp, 1 mg |
Mylan Specialty L.P. |
49502-0381-02 |
Hulio |
1 MG |
0.4 |
1 |
20 |
40 |
Q5140 |
Inj adalimumab-fkjp, 1 mg |
Mylan Specialty L.P. |
49502-0382-02 |
Hulio |
1 MG |
0.8 |
1 |
40 |
80 |
Q5140 |
Inj adalimumab-fkjp, 1 mg |
Biocon Biologics Inc |
83257-0016-42 |
Hulio |
1 MG |
0.4 |
2 |
20 |
40 |
Q5140 |
Inj adalimumab-fkjp, 1 mg |
Biocon Biologics Inc |
83257-0017-42 |
Hulio |
1 MG |
0.8 |
1 |
40 |
80 |
Q5140 |
Inj adalimumab-fkjp, 1 mg |
Biocon Biologics Inc |
83257-0019-32 |
Hulio |
1 MG |
0.8 |
1 |
40 |
80 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0023-01 |
Yuflyma |
1 MG |
0.8 |
1 |
80 |
80 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0023-02 |
Yuflyma |
1 MG |
0.8 |
1 |
80 |
80 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0023-03 |
Yuflyma |
1 MG |
0.8 |
2 |
80 |
160 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0023-04 |
Yuflyma |
1 MG |
0.8 |
1 |
80 |
80 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0023-05 |
Yuflyma |
1 MG |
0.8 |
2 |
80 |
160 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0023-07 |
Yuflyma |
1 MG |
0.8 |
3 |
80 |
240 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0023-08 |
Yuflyma |
1 MG |
0.8 |
3 |
80 |
240 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0024-01 |
Yuflyma |
1 MG |
0.2 |
2 |
20 |
40 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-01 |
Yuflyma |
1 MG |
0.4 |
1 |
40 |
40 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-02 |
Yuflyma |
1 MG |
0.4 |
2 |
40 |
80 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-03 |
Yuflyma |
1 MG |
0.4 |
4 |
40 |
160 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-04 |
Yuflyma |
1 MG |
0.4 |
6 |
40 |
240 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-05 |
Yuflyma |
1 MG |
0.4 |
1 |
40 |
40 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-06 |
Yuflyma |
1 MG |
0.4 |
2 |
40 |
80 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-07 |
Yuflyma |
1 MG |
0.4 |
4 |
40 |
160 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-08 |
Yuflyma |
1 MG |
0.4 |
6 |
40 |
240 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-09 |
Yuflyma |
1 MG |
0.4 |
1 |
40 |
40 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-10 |
Yuflyma |
1 MG |
0.4 |
2 |
40 |
80 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-11 |
Yuflyma |
1 MG |
0.4 |
4 |
40 |
160 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-12 |
Yuflyma |
1 MG |
0.4 |
6 |
40 |
240 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-13 |
Yuflyma |
1 MG |
0.4 |
4 |
40 |
160 |
Q5141 |
Inj adalimumab-aaty, 1 mg |
Celltrion USA Inc. |
72606-0030-14 |
Yuflyma |
1 MG |
0.4 |
6 |
40 |
240 |
Q5142 |
Inj adalimumab-ryvk, 1 mg |
Teva Pharmaceuticals USA, Inc. |
51759-0274-17 |
Simlandi |
1 MG |
0.8 |
1 |
80 |
80 |
Q5142 |
Inj adalimumab-ryvk, 1 mg |
Nupathe Inc |
51759-0386-22 |
Simlandi |
1 MG |
0.2 |
2 |
20 |
40 |
Q5142 |
Inj adalimumab-ryvk, 1 mg |
Nupathe Inc |
51759-0402-02 |
Simlandi |
1 MG |
0.4 |
2 |
40 |
80 |
Q5142 |
Inj adalimumab-ryvk, 1 mg |
Nupathe Inc |
51759-0402-17 |
Simlandi |
1 MG |
0.4 |
1 |
40 |
40 |
Q5142 |
Inj adalimumab-ryvk, 1 mg |
Nupathe Inc |
51759-0412-22 |
Simlandi |
1 MG |
0.4 |
2 |
40 |
80 |
Q5142 |
Inj adalimumab-ryvk, 1 mg |
Nupathe Inc |
51759-0523-21 |
Simlandi |
1 MG |
0.8 |
1 |
80 |
80 |
Q5142 |
Inj adalimumab-ryvk, 1 mg |
Quallent Pharmaceuticals |
82009-0156-22 |
Adalimumab-ryvk |
1 MG |
0.4 |
2 |
40 |
80 |
Q5142 |
Inj adalimumab-ryvk, 1 mg |
Quallent Pharmaceuticals |
82009-0158-22 |
Adalimumab-ryvk |
1 MG |
0.4 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Quallent Pharmaceuticals |
82009-0144-22 |
Adalimumab-adbm |
1 MG |
0.4 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Quallent Pharmaceuticals |
82009-0146-22 |
Adalimumab-adbm |
1 MG |
0.4 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Quallent Pharmaceuticals |
82009-0148-22 |
Adalimumab-adbm |
1 MG |
0.8 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Quallent Pharmaceuticals |
82009-0150-22 |
Adalimumab-adbm |
1 MG |
0.8 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0370-82 |
Cyltezo |
1 MG |
0.8 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0375-16 |
Cyltezo |
1 MG |
0.8 |
6 |
40 |
240 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0375-23 |
Cyltezo |
1 MG |
0.8 |
4 |
40 |
160 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0375-97 |
Cyltezo |
1 MG |
0.8 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0400-89 |
Cyltezo |
1 MG |
0.2 |
2 |
10 |
20 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0405-80 |
Cyltezo |
1 MG |
0.4 |
2 |
20 |
40 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0485-20 |
Cyltezo |
1 MG |
0.4 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0495-40 |
Cyltezo |
1 MG |
0.4 |
4 |
40 |
160 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0495-50 |
Cyltezo |
1 MG |
0.4 |
2 |
40 |
80 |
Q5143 |
Inj adalimumab-adbm, 1 mg |
Boehringer Ingelheim Pharmaceuticals Inc |
00597-0495-60 |
Cyltezo |
1 MG |
0.4 |
6 |
40 |
240 |
Q5144 |
Inj, idacio, 1 mg |
FreseniUS Kabi USA, LLC |
65219-0612-69 |
Adalimumab-aacf |
1 MG |
0.8 |
4 |
40 |
160 |
Q5144 |
Inj, idacio, 1 mg |
FreseniUS Kabi USA, LLC |
65219-0612-89 |
Adalimumab-aacf |
1 MG |
0.8 |
6 |
40 |
240 |
Q5144 |
Inj, idacio, 1 mg |
FreseniUS Kabi USA, LLC |
65219-0612-99 |
Adalimumab-aacf |
1 MG |
0.8 |
2 |
40 |
80 |
Q5144 |
Inj, idacio, 1 mg |
FreseniUS Kabi USA, LLC |
65219-0620-20 |
Adalimumab-Aacf |
1 MG |
0.8 |
2 |
40 |
80 |
Q5144 |
Inj, idacio, 1 mg |
FreseniUS Kabi USA, LLC |
65219-0554-08 |
Idacio |
1 MG |
0.8 |
2 |
40 |
80 |
Q5144 |
Inj, idacio, 1 mg |
FreseniUS Kabi USA, LLC |
65219-0554-28 |
Idacio |
1 MG |
0.8 |
4 |
40 |
160 |
Q5144 |
Inj, idacio, 1 mg |
FreseniUS Kabi USA, LLC |
65219-0554-38 |
Idacio |
1 MG |
0.8 |
6 |
40 |
240 |
Q5144 |
Inj, idacio, 1 mg |
FreseniUS Kabi USA, LLC |
65219-0556-18 |
Idacio |
1 MG |
0.8 |
2 |
40 |
80 |
Q5145 |
Inj, abrilada, 1 mg |
PFIZER LABS |
00025-0325-01 |
Abrilada |
1 MG |
0.8 |
1 |
40 |
40 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc. |
00025-0325-02 |
Abrilada |
1 MG |
0.8 |
2 |
40 |
80 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc. |
00025-0328-02 |
Abrilada |
1 MG |
0.8 |
2 |
40 |
80 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc |
00069-0319-01 |
Abrilada |
1 MG |
0.8 |
1 |
40 |
40 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc |
00069-0325-01 |
Abrilada |
1 MG |
0.8 |
1 |
40 |
40 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc |
00069-0325-02 |
Abrilada |
1 MG |
0.8 |
2 |
40 |
80 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc |
00069-0328-01 |
Abrilada |
1 MG |
0.8 |
1 |
40 |
40 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc |
00069-0328-02 |
Abrilada |
1 MG |
0.8 |
2 |
40 |
80 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc |
00069-0333-02 |
Abrilada |
1 MG |
0.4 |
2 |
20 |
40 |
Q5145 |
Inj, abrilada, 1 mg |
Pfizer Inc |
00069-0347-02 |
Abrilada |
1 MG |
0.2 |
2 |
10 |
20 |
Q5148 |
Inj, nyposi 1 mcg |
Tanvex Biopharma USA |
72374-0101-01 |
Nypozi |
1 MCG |
0.5 |
1 |
300 |
300 |
Q5148 |
Inj, nyposi 1 mcg |
Tanvex Biopharma USA |
72374-0101-10 |
Nypozi |
1 MCG |
0.5 |
10 |
300 |
3000 |
Q5148 |
Inj, nyposi 1 mcg |
Tanvex Biopharma USA |
72374-0102-01 |
Nypozi |
1 MCG |
0.8 |
1 |
480 |
480 |
Q5148 |
Inj, nyposi 1 mcg |
Tanvex Biopharma USA |
72374-0102-10 |
Nypozi |
1 MCG |
0.8 |
10 |
480 |
4800 |
Q5151 |
Inj, eculizumab-aagh, 2 mg |
Teva Pharmaceuticals USA, Inc. |
51759-0208-13 |
Epysqli |
2 MG |
30 |
1 |
150 |
150 |
Q5151 |
Inj, eculizumab-aagh, 2 mg |
Samsung Bioepis |
71202-0010-01 |
Epysqli |
2 MG |
30 |
1 |
150 |
150 |
Q5152 |
Inj, eculizumab-aeeb, 2 mg |
Amgen Inc |
55513-0180-01 |
Bkemv |
2 MG |
30 |
1 |
150 |
150 |
Q5157 |
Inj, denosumab-bmwo, 1 mg |
Celltrion USA Inc. |
72606-0038-01 |
Osenvelt |
1 MG |
1.7 |
1 |
120 |
120 |
Q5157 |
Inj, denosumab-bmwo, 1 mg |
Celltrion USA Inc. |
72606-0037-01 |
Stoboclo |
1 MG |
1 |
1 |
60 |
60 |
Q5158 |
Inj, denosumab-bnht, 1 mg |
Fresenius Kabi USA, LLC |
65219-0670-01 |
Bomyntra |
1 MG |
1.7 |
1 |
120 |
120 |
Q5158 |
Inj, denosumab-bnht, 1 mg |
Fresenius Kabi USA, LLC |
65219-0672-01 |
Bomyntra |
1 MG |
1.7 |
1 |
120 |
120 |
Q5158 |
Inj, denosumab-bnht, 1 mg |
Fresenius Kabi USA, LLC |
65219-0668-01 |
Conexxence |
1 MG |
1 |
1 |
60 |
60 |
Q9968 |
Visualization adjunct |
Mylan Institutional LLC |
67457-0220-05 |
Isosulfan Blue |
1 MG |
5 |
6 |
50 |
300 |
Q9968 |
Visualization adjunct |
American Regent, Inc. |
00517-0374-05 |
Provayblue |
1 MG |
10 |
5 |
50 |
250 |
Q9982 |
Flutemetamol F18 |
GE Healthcare Inc. |
17156-0067-30 |
Vizamyl |
Per Study Dose, up to 5 millicuries |
1 |
1 |
1 |
1 |